I agree with you, Husker. I've said that Amgen is the leading candidate to buy ADXS ever since the Amgen deal. The fit just makes too much sense, for both cancer and for infectious diseases, as you noted. Quite a platform, this attenuated Listeria. Nice work on the stuff you sent to IR.
News 
Market Data 
Discover 
